Income Statement Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
104.85 ^USD	+2.03%		+2.95%	+2.65%

02-02	Guardant Health, Inc. Announces Publication of the Largest Study to Date Evaluating Circulating Tumors forMRD Detection in Patients with Rescted Stage III Colon Cancer After Surgery and Before Adjuvant Chemotherapy	CI
01-30	UBS Adjusts Price Target on Guardant Health to $175 From $110, Maintains Buy Rating	MT

4f15a818f9.yf2zuTuvE-o5tdicXICawPCvC7eKaKiE3pyZ5nOK4t0.n8n6ym3gcK0IhOrqD9D8rJieSPTZBOb3nKrfhQvEpoKBrorgY8B1ugrlsw

Published financial data: GUARDANT HEALTH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	287M	374M	450M	564M	739M
Total Revenues	287M	374M	450M	564M	739M
Cost of Goods Sold, Total	92.54M	123M	156M	227M	290M
Gross Profit	194M	251M	293M	337M	449M
Selling General & Admin Expenses, Total	298M	399M	464M	451M	545M
R&D Expenses	141M	263M	374M	365M	348M
Other Operating Expenses, Total	439M	662M	838M	816M	893M
Operating Income	-245M	-411M	-544M	-479M	-444M
Interest Expense, Total	-4.77M	-2.58M	-2.58M	-2.58M	-2.58M
Interest And Investment Income	10.17M	3.93M	6.07M	35.36M	53.69M
Net Interest Expenses	5.4M	1.35M	3.49M	32.79M	51.11M
Currency Exchange Gains (Loss)	500K	-	-	-	-
Other Non Operating Income (Expenses)	1.34M	178K	-99.47M	2.52M	1.8M
EBT, Excl. Unusual Items	-238M	-409M	-640M	-444M	-391M
Merger & Related Restructuring Charges	-9.71M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-13.09M	50.66M	-44.4M
Legal Settlements	-	-	-	-83.4M	-
Other Unusual Items	1.8M	25M	-	-2.1M	-
EBT, Incl. Unusual Items	-246M	-384M	-653M	-479M	-435M
Income Tax Expense	379K	300K	1.14M	685K	1.28M
Earnings From Continuing Operations	-246M	-385M	-655M	-479M	-436M
Net Income to Company	-246M	-385M	-655M	-479M	-436M
Minority Interest	-7.5M	-20.9M	-	-	-
Net Income - (IS)	-254M	-406M	-655M	-479M	-436M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-254M	-406M	-655M	-479M	-436M
Net Income to Common Excl. Extra Items	-254M	-406M	-655M	-479M	-436M
Per Share Items
Net EPS - Basic	-2.6	-4	-6.41	-4.28	-3.56
Basic EPS - Continuing Operations	-2.6	-4	-6.41	-4.28	-3.56
Basic Weighted Average Shares Outstanding	97.5M	101M	102M	112M	123M
Net EPS - Diluted	-2.6	-4	-6.41	-4.28	-3.56
Diluted EPS - Continuing Operations	-2.6	-4	-6.41	-4.28	-3.56
Diluted Weighted Average Shares Outstanding	97.5M	101M	102M	112M	123M
Normalized Basic EPS	-1.6	-2.73	-3.92	-2.48	-1.99
Normalized Diluted EPS	-1.6	-2.73	-3.92	-2.48	-1.99
Supplemental Items
EBITDA	-229M	-389M	-508M	-436M	-401M
EBITA	-241M	-409M	-542M	-477M	-441M
EBIT	-245M	-411M	-544M	-479M	-444M
EBITDAR	-224M	-364M	-480M	-407M	-370M
Total Revenues (As Reported)	287M	374M	450M	564M	739M
Effective Tax Rate - (Ratio)	-0.15	-0.08	-0.17	-0.14	-0.3
Current Domestic Taxes	5K	4K	127K	35K	126K
Current Foreign Taxes	242K	118K	1.25M	1.19M	871K
Total Current Taxes	247K	122K	1.38M	1.23M	997K
Deferred Domestic Taxes	218K	128K	21K	-	-
Deferred Foreign Taxes	-86K	50K	-257K	-541K	287K
Total Deferred Taxes	132K	178K	-236K	-541K	287K
Normalized Net Income	-156M	-277M	-400M	-277M	-244M
Interest on Long-Term Debt	4.77M	2.58M	2.58M	2.58M	2.58M
Supplemental Operating Expense Items
Advertising Expense	1.2M	2.4M	8.9M	2.1M	-
Selling and Marketing Expenses	107M	192M	300M	295M	365M
General and Administrative Expenses	192M	207M	164M	156M	180M
Research And Development Expense From Footnotes	168M	263M	374M	367M	348M
Net Rental Expense, Total	5.6M	24.7M	28.6M	29.7M	31.1M
Imputed Operating Lease Interest Expense	477K	457K	430K	450K	477K
Imputed Operating Lease Depreciation	5.12M	24.24M	28.17M	29.25M	30.62M
Stock-Based Comp., COGS (Total)	1.84M	3.47M	5.5M	6.46M	9.36M
Stock-Based Comp., R&D Exp. (Total)	10.02M	18.91M	26.63M	34.68M	50.57M
Stock-Based Comp., S&M Exp. (Total)	9.28M	15.48M	25.44M	24.76M	36.48M
Stock-Based Comp., G&A Exp. (Total)	123M	114M	37.12M	24.85M	44M
Total Stock-Based Compensation	144M	151M	94.68M	90.76M	140M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	833M	492M	142M	1.13B	526M
Short Term Investments	962M	441M	870M	35.1M	314M
Total Cash And Short Term Investments	1.79B	933M	1.01B	1.17B	840M
Accounts Receivable, Total	53.3M	97.65M	97.26M	88.78M	110M
Total Receivables	53.3M	97.65M	97.26M	88.78M	110M
Inventory	22.72M	30.67M	51.6M	61.95M	71.08M
Prepaid Expenses	17.47M	53.05M	31.51M	27.74M	33.8M
Total Current Assets	1.89B	1.11B	1.19B	1.35B	1.06B
Gross Property Plant And Equipment	134M	369M	430M	430M	445M
Accumulated Depreciation	-34.34M	-54.82M	-88.13M	-127M	-166M
Net Property Plant And Equipment	100M	314M	342M	303M	279M
Long-term Investments	247M	737M	25M	107M	16.1M
Goodwill	3.29M	3.29M	3.29M	3.29M	3.29M
Other Intangibles, Total	16.2M	14.21M	11.73M	8.98M	6.76M
Accounts Receivable Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	17.21M	21.54M	36.45M	17.73M	125M
Total Assets	2.27B	2.2B	1.61B	1.79B	1.49B
Liabilities
Accounts Payable, Total	7.34M	17.58M	68.91M	51.74M	38.55M
Accrued Expenses, Total	38.5M	64.81M	55.79M	72.74M	83.22M
Current Portion of Leases	6.63M	12.86M	21.88M	27.95M	29.21M
Current Income Taxes Payable	4.63M	4.22M	-	-	-
Unearned Revenue Current, Total	8.55M	11.33M	17.4M	17.96M	35.47M
Other Current Liabilities	1.16M	83.89M	29.24M	35.52M	39.13M
Total Current Liabilities	66.81M	195M	193M	206M	226M
Long-Term Debt	806M	1.13B	1.14B	1.14B	1.14B
Long-Term Leases	41.56M	226M	210M	186M	164M
Unearned Revenue Non Current	-	-	-	5M	41.6M
Other Non Current Liabilities	1.52M	3.93M	9.18M	91.01M	51.23M
Total Liabilities	916M	1.56B	1.55B	1.63B	1.63B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	1K	1K	1K	1K	1K
Additional Paid In Capital	1.9B	1.66B	1.74B	2.3B	2.44B
Retained Earnings	-607M	-1.01B	-1.66B	-2.14B	-2.58B
Comprehensive Income and Other	2.7M	-4.76M	-19.52M	-3.68M	-5.2M
Total Common Equity	1.3B	645M	60.18M	159M	-140M
Minority Interest	57.1M	-	-	-	-
Total Equity	1.36B	645M	60.18M	159M	-140M
Total Liabilities And Equity	2.27B	2.2B	1.61B	1.79B	1.49B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	100M	102M	103M	122M	123M
ECS Total Common Shares Outstanding	100M	102M	103M	122M	124M
Book Value / Share	12.96	6.34	0.59	1.3	-1.13
Tangible Book Value	1.28B	628M	45.16M	146M	-150M
Tangible Book Value Per Share	12.76	6.17	0.44	1.2	-1.21
Total Debt	854M	1.37B	1.37B	1.35B	1.34B
Net Debt	-1.19B	-257M	358M	185M	496M
Debt Equivalent Oper. Leases	44.8M	198M	229M	238M	249M
Minority Interest, Total (Incl. Fin. Div)	57.1M	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Others	22.72M	30.67M	51.6M	61.95M	71.08M
Machinery, Total	54.12M	83.39M	134M	161M	169M
Full Time Employees	864	1.37K	1.79K	1.77K	2K
Part Time Employees	-	-	-	11	22

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-254M	-406M	-655M	-479M	-436M
Depreciation & Amortization - CF	11.83M	20.37M	33.46M	40.18M	40.19M
Amortization of Goodwill and Intangible Assets - (CF)	4.23M	1.9M	2.5M	2.7M	2.2M
Depreciation & Amortization, Total	16.06M	22.27M	35.96M	42.88M	42.39M
Amortization of Deferred Charges, Total - (CF)	4.73M	2.56M	2.57M	2.58M	2.58M
(Gain) Loss on Sale of Investments - (CF)	4.02M	12.85M	12.39M	-64.21M	37.63M
Asset Writedown & Restructuring Costs	8.5M	-	5.26M	-	-
Provision for Credit Losses	7.15M	47K	21K	-	-
Stock-Based Compensation (CF)	144M	151M	94.68M	90.76M	140M
Other Operating Activities, Total	12.95M	47.94M	133M	28.63M	34.37M
Change In Accounts Receivable	-5.46M	-44.35M	375K	8.38M	-21.39M
Change In Inventories	-7.54M	-7.96M	-20.93M	-10.35M	-9.14M
Change In Accounts Payable	-7.86M	8.64M	60.33M	88.59M	-2.82M
Change in Unearned Revenues	-3.73M	2.78M	9.87M	1.73M	18.66M
Change in Other Net Operating Assets	-23.08M	428K	11.91M	-34.51M	-46.18M
Cash from Operations	-104M	-209M	-309M	-325M	-240M
Capital Expenditure	-36.17M	-75.04M	-77.46M	-20.49M	-35.08M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-17.89M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-563M	11.88M	227M	859M	-226M
Other Investing Activities, Total	-	-	-	1.53M	-
Cash from Investing	-617M	-63.16M	150M	840M	-261M
Long-Term Debt Issued, Total	1.13B	-	-	-	-
Total Debt Issued	1.13B	-	-	-	-
Long-Term Debt Repaid, Total	-174K	-146K	-71K	-	-
Total Debt Repaid	-174K	-146K	-71K	-	-
Issuance of Common Stock	372M	17.86M	11.94M	504M	14.84M
Repurchase of Common Stock	-3.45M	-83.76M	-7.88M	-11.2M	-15.68M
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-91.18M	-784K	-193M	-15.1M	-153K
Cash from Financing	1.41B	-66.82M	-189M	477M	-996K
Foreign Exchange Rate Adjustments	455K	-1.69M	-1.6M	-911K	-1.77M
Net Change in Cash	690M	-341M	-350M	992M	-504M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	331K	393K	1.33M	1.97M	1.01M
Levered Free Cash Flow	-69.75M	-123M	-296M	-177M	-147M
Unlevered Free Cash Flow	-71.5M	-124M	-297M	-178M	-148M
Change In Net Working Capital	24.34M	-33.76M	9.47M	-8.52M	18.26M
Net Debt Issued / Repaid	1.13B	-146K	-71K	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-9.48	-11.48	-17.84	-17.64	-16.95
Return on Total Capital	-9.89	-12.15	-19.73	-20.36	-20.47
Return On Equity %	-22.35	-38.47	-185.65	-438.12	-4.58K
Return on Common Equity	-24.21	-41.75	-185.65	-438.12	-4.58K
Margin Analysis
Gross Profit Margin %	67.73	67.11	65.23	59.74	60.79
SG&A Margin	103.96	106.66	103.17	79.98	73.75
EBITDA Margin %	-79.93	-104.04	-113.1	-77.37	-54.29
EBITA Margin %	-84.06	-109.49	-120.54	-84.5	-59.73
EBIT Margin %	-85.53	-110	-121.1	-84.98	-60.02
Income From Continuing Operations Margin %	-85.89	-102.98	-145.61	-85.02	-59.05
Net Income Margin %	-88.51	-108.57	-145.61	-85.02	-59.05
Net Avail. For Common Margin %	-88.51	-108.57	-145.61	-85.02	-59.05
Normalized Net Income Margin	-54.49	-74.08	-89.03	-49.2	-33.04
Levered Free Cash Flow Margin	-24.33	-33.05	-65.75	-31.36	-19.87
Unlevered Free Cash Flow Margin	-24.94	-33.3	-65.96	-31.54	-20
Asset Turnover
Asset Turnover	0.18	0.17	0.24	0.33	0.45
Fixed Assets Turnover	3.32	1.8	1.37	1.75	2.54
Receivables Turnover (Average Receivables)	5.66	4.95	4.61	6.06	7.43
Inventory Turnover (Average Inventory)	4.88	4.6	3.8	4	4.36
Short Term Liquidity
Current Ratio	28.27	5.72	6.17	6.54	4.68
Quick Ratio	27.66	5.29	5.74	6.11	4.21
Operating Cash Flow to Current Liabilities	-1.56	-1.07	-1.6	-1.58	-1.06
Days Sales Outstanding (Average Receivables)	64.64	73.73	79.13	60.2	49.29
Days Outstanding Inventory (Average Inventory)	74.95	79.27	96.05	91.27	84.01
Average Days Payable Outstanding	43.04	34.75	110.61	92.75	55.27
Cash Conversion Cycle (Average Days)	96.55	118.25	64.56	58.72	78.02
Long Term Solvency
Total Debt/Equity	63.03	212.98	2.28K	853.12	-956.74
Total Debt / Total Capital	38.66	68.05	95.79	89.51	111.67
LT Debt/Equity	62.54	210.99	2.24K	835.51	-935.82
Long-Term Debt / Total Capital	38.36	67.41	94.26	87.66	109.23
Total Liabilities / Total Assets	40.33	70.74	96.26	91.12	109.4
EBIT / Interest Expense	-51.46	-159.49	-211.24	-185.89	-171.87
EBITDA / Interest Expense	-46.91	-141.26	-186.19	-157.74	-143.4
(EBITDA - Capex) / Interest Expense	-54.5	-170.38	-216.25	-165.68	-156.99
Total Debt / EBITDA	-3.82	-3.77	-2.85	-3.33	-3.61
Net Debt / EBITDA	5.31	0.71	-0.75	-0.46	-1.34
Total Debt / (EBITDA - Capex)	-3.29	-3.13	-2.46	-3.17	-3.3
Net Debt / (EBITDA - Capex)	4.57	0.59	-0.64	-0.43	-1.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	33.75	30.32	20.31	25.45	31.04
Gross Profit, 1 Yr. Growth %	35.18	29.12	16.94	14.9	33.34
EBITDA, 1 Yr. Growth %	224.9	62.73	30.79	-13.29	-8.49
EBITA, 1 Yr. Growth %	202.88	61.6	32.46	-11.21	-7.78
EBIT, 1 Yr. Growth %	199.26	61.21	32.45	-11.12	-7.84
Earnings From Cont. Operations, 1 Yr. Growth %	262.98	56.23	70.12	-26.76	-8.98
Net Income, 1 Yr. Growth %	235.47	59.85	61.36	-26.76	-8.98
Normalized Net Income, 1 Yr. Growth %	205.69	70.54	44.58	-30.11	-12.41
Diluted EPS Before Extra, 1 Yr. Growth %	211.7	53.84	60	-33.17	-16.96
Accounts Receivable, 1 Yr. Growth %	11.07	83.22	-0.41	-8.71	24.18
Inventory, 1 Yr. Growth %	49.63	35.03	68.21	20.06	14.75
Net Property, Plant and Equip., 1 Yr. Growth %	37.52	213.51	8.93	-11.47	-7.81
Total Assets, 1 Yr. Growth %	136.02	-2.96	-26.97	10.96	-16.84
Tangible Book Value, 1 Yr. Growth %	64.04	-50.94	-92.8	224.19	-202.24
Common Equity, 1 Yr. Growth %	62.64	-50.33	-90.67	163.68	-188
Cash From Operations, 1 Yr. Growth %	120.49	101.12	48.06	5.01	-26.19
Capital Expenditures, 1 Yr. Growth %	93.26	107.43	3.23	-73.55	71.26
Levered Free Cash Flow, 1 Yr. Growth %	37.43	62.87	139.36	-39.49	-17.6
Unlevered Free Cash Flow, 1 Yr. Growth %	42.96	60.42	138.3	-39.36	-17.51
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	77.86	32.02	25.21	22.85	28.22
Gross Profit, 2 Yr. CAGR %	102.35	32.12	22.88	15.91	23.78
EBITDA, 2 Yr. CAGR %	63.43	134.05	45.89	5.95	-11.17
EBITA, 2 Yr. CAGR %	61.82	123.81	46.31	7.93	-9.75
EBIT, 2 Yr. CAGR %	62.44	123.37	46.12	7.98	-9.73
Earnings From Cont. Operations, 2 Yr. CAGR %	70.96	138.13	63.03	11.63	-18.35
Net Income, 2 Yr. CAGR %	72.73	131.57	60.6	8.71	-18.35
Normalized Net Income, 2 Yr. CAGR %	66.89	132.12	57.57	0.11	-21.89
Diluted EPS Before Extra, 2 Yr. CAGR %	-3.55	118.98	56.89	3.4	-25.51
Accounts Receivable, 2 Yr. CAGR %	22.2	42.65	35.08	-4.65	6.47
Inventory, 2 Yr. CAGR %	57.68	42.15	50.71	42.11	17.37
Net Property, Plant and Equip., 2 Yr. CAGR %	79.71	107.64	84.8	-1.8	-9.66
Total Assets, 2 Yr. CAGR %	96.66	51.34	-15.82	-9.98	-3.94
Tangible Book Value, 2 Yr. CAGR %	64.03	-10.29	-81.21	-51.7	82.06
Common Equity, 2 Yr. CAGR %	63.94	-10.12	-78.47	-50.4	52.33
Cash From Operations, 2 Yr. CAGR %	19.99	110.58	72.56	24.69	-11.96
Capital Expenditures, 2 Yr. CAGR %	33.81	100.22	46.34	-47.75	-32.7
Levered Free Cash Flow, 2 Yr. CAGR %	2.81	55.58	97.44	19.69	-29.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.72	57.32	95.52	19.55	-29.4
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	79.18	60.34	28	25.29	25.52
Gross Profit, 3 Yr. CAGR %	120.06	74.2	26.85	20.16	21.45
EBITDA, 3 Yr. CAGR %	49.63	65.47	92.78	22.24	1.06
EBITA, 3 Yr. CAGR %	48.49	64.42	87.91	23.47	2.56
EBIT, 3 Yr. CAGR %	49.35	64.14	87.66	23.41	2.58
Earnings From Cont. Operations, 3 Yr. CAGR %	43.57	65.9	112.88	24.86	4.28
Net Income, 3 Yr. CAGR %	45.01	68.32	105.3	23.62	2.46
Normalized Net Income, 3 Yr. CAGR %	49.29	70.25	98.23	19.84	-4.1
Diluted EPS Before Extra, 3 Yr. CAGR %	-28.34	12.69	97.23	18.04	-3.89
Accounts Receivable, 3 Yr. CAGR %	60.93	39.87	26.55	18.54	4.13
Inventory, 3 Yr. CAGR %	46.08	49.74	50.35	39.71	32.33
Net Property, Plant and Equip., 3 Yr. CAGR %	84.14	116.34	67.46	44.6	-3.84
Total Assets, 3 Yr. CAGR %	87.81	55.4	18.7	-7.7	-12.33
Tangible Book Value, 3 Yr. CAGR %	85.58	9.7	-61.31	-51.45	-37.98
Common Equity, 3 Yr. CAGR %	89.32	10.11	-57.76	-50.38	-39.95
Cash From Operations, 3 Yr. CAGR %	12.89	42.53	87.25	46.23	4.69
Capital Expenditures, 3 Yr. CAGR %	75.6	54.86	60.55	-17.26	-22.38
Levered Free Cash Flow, 3 Yr. CAGR %	7.4	23.23	79.6	32.63	5.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.4	24.04	80.67	31.86	5.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	71.41	55.25	44.14	28.08
Gross Profit, 5 Yr. CAGR %	-	140.37	74.3	48.01	25.61
EBITDA, 5 Yr. CAGR %	-	57.46	49.36	38.44	41.41
EBITA, 5 Yr. CAGR %	-	56.31	49.07	38.94	40.14
EBIT, 5 Yr. CAGR %	-	56.45	49.21	38.82	40.04
Earnings From Cont. Operations, 5 Yr. CAGR %	-	52.84	51.06	41.59	45.1
Net Income, 5 Yr. CAGR %	-	54.46	51.06	41.32	41.97
Normalized Net Income, 5 Yr. CAGR %	-	57.2	53.5	37.67	36.58
Diluted EPS Before Extra, 5 Yr. CAGR %	-	2.52	-1.96	8.88	33.61
Accounts Receivable, 5 Yr. CAGR %	-	94.65	50.05	19.99	18.1
Inventory, 5 Yr. CAGR %	-	61.77	47.92	46.64	36.17
Net Property, Plant and Equip., 5 Yr. CAGR %	-	90.13	84.4	57.73	30.83
Total Assets, 5 Yr. CAGR %	-	80.03	36.25	24.91	9.07
Tangible Book Value, 5 Yr. CAGR %	-	44.3	-25.75	-20.98	-28.11
Common Equity, 5 Yr. CAGR %	-	45.09	-20.66	-19.96	-29.44
Cash From Operations, 5 Yr. CAGR %	-	41.61	33.77	35.11	38.46
Capital Expenditures, 5 Yr. CAGR %	-	111.67	63.25	0.28	13.39
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	39.32	21.8	23.54
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	40.27	22.22	24.07